Growing Burden of Non-Communicable Diseases in the Emerging Health Markets: The Case of BRICS
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The blooming of incidence and prevalence of "prosperity diseases" among the broad layers of modern day populations is rather novel phenomenon in demographic history of the human race (1).Illnesses such as obesity (2), diabetes mellitus, hypertension, cerebrovascular and cardiovascular consequences of atherosclerosis, renal insufficiency, mental disorders, and even cancer are closely related to the increased longevity of most contemporary societies (3).In previous centuries, they were mostly reserved for elite social groups enjoying rather luxurious life style.Vast majority of citizens of the time were living in rural communities on the verge of poverty.Their structure of morbidity even in Europe until late 19th century was dominated by burden of infectious diseases and injury while neonatal and maternal mortality rates were huge.Industrial revolution led to the growth of living standards, invention of vaccines, and antibiotics, and ultimately development of organized publicly funded health systems.The prominent European health policy makers in the 19th century properly believed that effective public health measures will diminish huge burden of infectious diseases.Consecutively, they expected that overall costs of medical care provision should decrease substantially and ultimately reach plateau level.This second step turned out to be a great miscalculation and a surprise.Like no time in written past, people began living longer and healthier lives.But it happened at the cost.Simultaneously, from many industrialized nations, evidence were accumulating of accelerated occurrence of non-communicable diseases.Accomplishment of evidence-based medicine succeeded to control many of these initially incurable diseases, thereby transforming them into life time disorders as in the typical cases of diabetes and terminal renal insufficiency.Acute bacterial infections, dominating morbidity in the old days, were usually successfully treated within few weeks.Unlike these, chronic illnesses were bringing long-term burden for both the patients and the society.Malignant disorders with its complex treatment strategies present particularly demanding medical conditions.Cancer leaves permanent footprint in a life of a patient in terms of poor survival rates, decreased life quality, and working ability. Non-Communicable Diseases Expansion in Developing CountriesThe ultimate demographic transition consisting of ascending portion of elderly, falling fertility rates, and bold growth of median age within contemporary nations became broadly recognized as population aging (4).Most of this transformation of morbidity and mortality structure happened
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UN High-Level meeting on non-communicable diseases: addressing four questions
Beaglehole, R., Bonita, R., Alleyne, G., Horton, R., Li, L., Lincoln, P., Mbanya, J. C., McKee, M., Moodie, R., Nishtar, S., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60879-9 · Cited by 402
Universal health coverage: the third global health transition?
Rodin, J., & de Ferranti, D. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61340-3 · Cited by 141 · cited 1×
“The most challenging issue for the emerging markets’ health systems appears to be universal health coverage (30).”
Background
Cited by
Wang, H., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abera, S. F., Abraha, H. N., Abu-Raddad, L. J., Abu-Rmeileh, N. M. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31833-0 · Cited by 801
Review of Diagnosis-Related Group-Based Financing of Hospital Care
Mihailovic, N., Kocic, S., & Jakovljevic, M. (2016) · Health Services Research and Managerial Epidemiology · doi:10.1177/2333392816647892 · Cited by 138
The impact of health expenditures on public health in BRICS nations
Jakovljevic, M., Timofeyev, Y., Ekkert, N. V., Fedorova, J. V., Skvirskaya, G., Bolevich, S., & Reshetnikov, V. A. (2019) · Journal of Sport and Health Science · doi:10.1016/j.jshs.2019.09.002 · Cited by 119
“These economies still fight to eliminate infectious diseases while simultaneously being faced with a rising tide of noncommunicable diseases (NCDs).(4)”
Ahmed, M. M., Okesanya, O. J., Olaleke, N. O., Adigun, O. A., Adebayo, U. O., Oso, T. A., Eshun, G., & Lucero-Prisno, D. E. (2025) · Healthcare · doi:10.3390/healthcare13091060 · Cited by 106
Interventions to improve adherence to lipid-lowering drugs: a systematic review and meta-analysis
Yow, D. K. W., Ang, W. J., Yap, H. J., Ito, S., Liu, J., Ko, J., Tan, D. S.-Y., Lorenzatti, A., & Ang, C.-S. (2025) · eClinicalMedicine · doi:10.1016/j.eclinm.2025.103270 · Cited by 5
Metadata
- Authors
- Jakovljevic, M. B., & Milovanovic, O.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2015-04-23
- Volume
- 3
- Pages
- 65-65
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W2046115891
- Cited by
- 131
- References
- 2
- FWCI
- 17.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.